Castle Creek Arbitrage’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-39,144
Closed -$97.1K 361
2023
Q2
$97.1K Hold
39,144
0.01% 160
2023
Q1
$57.7K Hold
39,144
0.01% 222
2022
Q4
$75.2K Hold
39,144
0.01% 259
2022
Q3
$15K Hold
39,144
﹤0.01% 512
2022
Q2
$24K Hold
39,144
﹤0.01% 500
2022
Q1
$36K Hold
39,144
﹤0.01% 548
2021
Q4
$80K Buy
+39,144
New +$59.7K ﹤0.01% 554

Castle Creek Arbitrage's ROIVW Position: Q3 2023 in Review

Castle Creek Arbitrage sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 39,144 shares — an estimated $97.1K sold.

Castle Creek Arbitrage first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $97.1K in Q2 2023. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

  • Castle Creek Arbitrage reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 39,144 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $97.1K.
  • Castle Creek Arbitrage first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
  • Castle Creek Arbitrage's Roivant Sciences Ltd. Warrant position peaked at $97.1K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Castle Creek Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.